{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:21:20Z","timestamp":1769761280382,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11033-023-08818-2","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T16:02:05Z","timestamp":1698681725000},"page":"10005-10013","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The relationship between DNA methyltransferase 3B (DNMT3B) and miR 124-3pa expressions in bladder cancer tissues"],"prefix":"10.1007","volume":"50","author":[{"given":"Mohammed S.","family":"Fawzy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel Rahman M.","family":"El Faiomy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansam M. Z.","family":"El Desoky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"issue":"10","key":"8818_CR1","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.3390\/cancers14102423","volume":"14","author":"A Madej","year":"2022","unstructured":"Madej A, Forma E, Golberg M et al (2022) 13\u00a0C natural isotope abundance in Urothelium as a new marker in the Follow-Up of patients with bladder Cancer. Cancers 14(10):2423","journal-title":"Cancers"},{"issue":"1","key":"8818_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-74807-1","volume":"10","author":"DA Gaber","year":"2020","unstructured":"Gaber DA, Wassef RM, El-Ayat WM et al (2020) Role of a schistosoma haematobium specific microRNA as a predictive and prognostic tool for bilharzial bladder cancer in Egypt. Sci Rep 10(1):1\u201310","journal-title":"Sci Rep"},{"issue":"3","key":"8818_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.6004\/jnccn.2020.0011","volume":"18","author":"TW Flaig","year":"2020","unstructured":"Flaig TW, Spiess PE, Agarwal N et al (2020) Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 18(3):329\u2013354","journal-title":"J Natl Compr Canc Netw"},{"key":"8818_CR4","doi-asserted-by":"crossref","unstructured":"Lobo N, Afferi L, Moschini M et al (2022) Epidemiology, screening, and Prevention of bladder Cancer. European Urology Oncology","DOI":"10.1016\/j.euo.2022.10.003"},{"issue":"25","key":"8818_CR5","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.7150\/jca.37335","volume":"10","author":"L Chen","year":"2019","unstructured":"Chen L, Liu Y, Zhang Q et al (2019) p53\/PCDH17\/Beclin-1 proteins as prognostic predictors for urinary bladder cancer. J Cancer 10(25):6207","journal-title":"J Cancer"},{"issue":"9","key":"8818_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11912-021-01091-1","volume":"23","author":"H Slovacek","year":"2021","unstructured":"Slovacek H, Zhuo J, Taylor JM (2021) Approaches to Non-MuscleInvasive bladder Cancer. Curr Oncol Rep 23(9):1\u201311","journal-title":"Curr Oncol Rep"},{"issue":"7","key":"8818_CR7","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.3390\/ijms23073996","volume":"23","author":"T Pozniak","year":"2022","unstructured":"Pozniak T, Shcharbin D, Bryszewska M (2022) Circulating microRNAs in Medicine. Int J Mol Sci 23(7):3996","journal-title":"Int J Mol Sci"},{"issue":"1","key":"8818_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-022-00441-w","volume":"11","author":"Q Zhu","year":"2023","unstructured":"Zhu Q, Zhang Y, Li M et al (2023) MiR-124-3p impedes the metastasis of non-small cell lung cancer via extracellular exosome transport and intracellular PI3K\/AKT signaling. Biomark Res 11(1):1\u201317","journal-title":"Biomark Res"},{"key":"8818_CR9","doi-asserted-by":"publisher","first-page":"154947","DOI":"10.1016\/j.phymed.2023.154947","volume":"119","author":"FT Hsu","year":"2023","unstructured":"Hsu FT, Liu WL, Lee SR, Jeng LB, Chen JH (2023) Unveiling nature\u2019s potential weapon: Magnolol\u2019s role in combating bladder cancer by upregulating the miR-124 and inactivating PKC-\u03b4\/ERK axis. Phytomedicine 119:154947. https:\/\/doi.org\/10.1016\/j.phymed.2023.154947Epub 2023 Jul 26. PMID: 37549536","journal-title":"Phytomedicine"},{"issue":"2","key":"8818_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-022-01943-1","volume":"40","author":"S Bhootra","year":"2023","unstructured":"Bhootra S, Jill N, Shanmugam G, Rakshit S, Sarkar K (2023) DNA methylation and cancer: transcriptional regulation, prognostic, and therapeutic perspective. Med Oncol 40(2):1\u201317","journal-title":"Med Oncol"},{"issue":"1","key":"8818_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-24186-6","volume":"12","author":"J Loaeza-Loaeza","year":"2022","unstructured":"Loaeza-Loaeza J, Cerecedo-Castillo AJ, Rodr\u00edguez-Ruiz HA et al (2022) DNMT3B overexpression downregulates genes with CpG islands, common motifs, and transcription factor binding sites that interact with DNMT3B. Sci Rep 12(1):1\u201313","journal-title":"Sci Rep"},{"issue":"28","key":"8818_CR12","doi-asserted-by":"publisher","first-page":"43109","DOI":"10.18632\/oncotarget.10097","volume":"7","author":"R Peres","year":"2016","unstructured":"Peres R, Furuya H, Pagano I, Shimizu Y, Hokutan K, Rosser CJ (2016) Angiogenin contributes to bladder cancer tumorigenesis by DNMT3b-mediated MMP2 activation. Oncotarget 7(28):43109\u201343123. https:\/\/doi.org\/10.18632\/oncotarget.10097PMID: 27317771; PMCID: PMC5190012","journal-title":"Oncotarget"},{"issue":"2","key":"8818_CR13","doi-asserted-by":"publisher","first-page":"e12751","DOI":"10.1111\/cpr.12751","volume":"53","author":"Y Ying","year":"2020","unstructured":"Ying Y, Li J, Xie H, Yan H, Jin K, He L, Ma X, Wu J, Xu X, Fang J, Wang X, Zheng X, Liu B, Xie L (2020) CCND1, NOP14 and DNMT3B are involved in mir-502-5p-mediated inhibition of cell migration and proliferation in bladder cancer. Cell Prolif 53(2):e12751. https:\/\/doi.org\/10.1111\/cpr.12751Epub 2020 Jan 23. PMID: 31971654; PMCID: PMC7048215","journal-title":"Cell Prolif"},{"key":"8818_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-1-0716-1818-9_9","volume-title":"Protocols in Advanced Genomics and Allied Techniques","author":"A Pal","year":"2022","unstructured":"Pal A (2022) Real-time or quantitative PCR. Protocols in Advanced Genomics and Allied Techniques. Springer, New York, NY, pp 181\u2013209"},{"key":"8818_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.33899\/ijvs.2021.131918.2023","volume":"35","author":"HB Al-Sabaawy","year":"2021","unstructured":"Al-Sabaawy HB, Rahawi AM, Al-Mahmood SS (2021) Standard techniques for formalin-fixed paraffin-embedded tissue: a pathologist\u2019s perspective. Iraqi J Veterinary Sci 35:127\u2013135","journal-title":"Iraqi J Veterinary Sci"},{"issue":"1","key":"8818_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-022-01312-5","volume":"15","author":"W Zhang","year":"2022","unstructured":"Zhang W, He X, Yin H et al (2022) Allosteric activation of the metabolic enzyme GPD1 inhibits bladder cancer growth via the lysoPC-PAFR-TRPV2 axis. J Hematol Oncol 15(1):1\u201317","journal-title":"J Hematol Oncol"},{"issue":"9","key":"8818_CR17","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.3390\/ijms22094483","volume":"22","author":"P Wigner","year":"2021","unstructured":"Wigner P, Gr\u0119bowski R, Bijak M, Saluk-Bijak J, Szemraj J (2021) The interplay between oxidative stress, inflammation and angiogenesis in bladder cancer development. Int J Mol Sci 22(9):4483","journal-title":"Int J Mol Sci"},{"issue":"2","key":"8818_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran L, Xiao JF, Agarwal N, Duex JE, Theodorescu D (2021) Advances in bladder cancer biology and therapy. Nat Rev Cancer 21(2):104\u2013121","journal-title":"Nat Rev Cancer"},{"key":"8818_CR19","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/978-1-0716-1170-8_18","volume-title":"miRNomics","author":"E Uzuner","year":"2022","unstructured":"Uzuner E, Ulu GT, G\u00fcrler SB, Baran Y (2022) The role of MiRNA in cancer: pathogenesis, diagnosis, and treatment. miRNomics. Humana, New York, NY, pp 375\u2013422"},{"issue":"2","key":"8818_CR20","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3892\/ijmm.2020.4804","volume":"47","author":"X Yang","year":"2021","unstructured":"Yang X, Wang J, Li H, Sun Y, Tong X (2021) Downregulation of hsa_circ_0026123 suppresses ovarian cancer cell metastasis and proliferation through the miR-124-3p\/EZH2 signaling pathway. Int J Mol Med 47(2):668\u2013676","journal-title":"Int J Mol Med"},{"issue":"1","key":"8818_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-020-01743-5","volume":"21","author":"B Zhu","year":"2021","unstructured":"Zhu B, Cui H, Xu W (2021) Hydrogen inhibits the proliferation and migration of gastric cancer cells by modulating lncRNA MALAT1\/miR-124-3p\/EZH2 axis. Cancer Cell Int 21(1):1\u201310","journal-title":"Cancer Cell Int"},{"key":"8818_CR22","doi-asserted-by":"crossref","unstructured":"Memari F, Tavakolpour V, Mohajeri N et al (2022) Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia. Clin Transl Oncol, 1\u20139","DOI":"10.1007\/s12094-022-02781-3"},{"key":"8818_CR23","doi-asserted-by":"crossref","unstructured":"Alshammari E, Zhang Y, Sobota J, Yang Z (2022) Aberrant DNA methylation of Tumor suppressor genes and oncogenes as Cancer biomarkers. Genomic and Epigenomic Biomarkers of Toxicology and Disease: Clinical and Therapeutic Actions, 251\u2013271","DOI":"10.1002\/9781119807704.ch12"},{"key":"8818_CR24","doi-asserted-by":"publisher","first-page":"103399","DOI":"10.1016\/j.critrevonc.2021.103399","volume":"164","author":"CS Flausino","year":"2021","unstructured":"Flausino CS, Daniel FI, Modolo F (2021) DNA methylation in oral squamous cell carcinoma: from its role in carcinogenesis to potential inhibitor drugs. Crit Rev Oncol\/Hematol 164:103399","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"10","key":"8818_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1080\/14737140.2020.1813029","volume":"20","author":"P Viswambaram","year":"2020","unstructured":"Viswambaram P, Hayne D (2020) Gender discrepancies in bladder cancer: potential explanations. Expert Rev Anticancer Ther 20(10):841\u2013849","journal-title":"Expert Rev Anticancer Ther"},{"issue":"8","key":"8818_CR26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41585-022-00611-3","volume":"19","author":"A Martin","year":"2022","unstructured":"Martin A, Woolbright BL, Umar S, Ingersoll MA, Taylor JA (2022) Bladder cancer, inflammageing and microbiomes. Nat Reviews Urol 19(8):495\u2013509","journal-title":"Nat Reviews Urol"},{"issue":"1","key":"8818_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3233\/CBM-160427","volume":"19","author":"Q Yuan","year":"2017","unstructured":"Yuan Q, Sun T, Ye F, Kong W, Jin H (2017) MicroRNA-124-3p affects proliferation, migration and apoptosis of bladder cancer cells through targeting AURKA. Cancer Biomarkers 19(1):93\u2013101","journal-title":"Cancer Biomarkers"},{"issue":"5","key":"8818_CR28","first-page":"5875","volume":"16","author":"S Wang","year":"2018","unstructured":"Wang S, Wu G, Han Y et al (2018) miR-124 regulates STAT3-mediated cell proliferation, migration and apoptosis in bladder cancer. Oncol Lett 16(5):5875\u20135881","journal-title":"Oncol Lett"},{"key":"8818_CR29","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.2147\/OTT.S193661","volume":"12","author":"Z Cao","year":"2019","unstructured":"Cao Z, Xu L, Zhao S, Zhu X (2019) The functions of microRNA-124 on bladder cancer. OncoTargets and Therapy 12:3429","journal-title":"OncoTargets and Therapy"},{"issue":"5","key":"8818_CR30","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.5114\/aoms.2018.78743","volume":"15","author":"W Fu","year":"2019","unstructured":"Fu W, Wu X, Yang Z, Mi H (2019) The effect of mir-124-3p on cell proliferation and apoptosis in bladder cancer by targeting EDNRB. Archives of Medical Science: AMS 15(5):1154","journal-title":"Archives of Medical Science: AMS"},{"issue":"2","key":"8818_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3233\/CBM-182000","volume":"24","author":"JR Wang","year":"2019","unstructured":"Wang JR, Liu B, Zhou L, Huang YX (2019) MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer. Cancer Biomarkers 24(2):159\u2013172","journal-title":"Cancer Biomarkers"},{"issue":"9","key":"8818_CR32","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3390\/genes13091629","volume":"13","author":"A Awadalla","year":"2022","unstructured":"Awadalla A, Abol-Enein H, Hamam ET et al (2022) Identification of epigenetic interactions between miRNA and gene expression as potential prognostic markers in bladder Cancer. Genes 13(9):1629","journal-title":"Genes"},{"issue":"12","key":"8818_CR33","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1002\/ijc.32036","volume":"144","author":"Q Ge","year":"2019","unstructured":"Ge Q, Lu M, Ju L et al (2019) Mir-4324\u2010RACGAP1\u2010STAT3\u2010ESR1 feedback loop inhibits proliferation and metastasis of bladder cancer. Int J Cancer 144(12):3043\u20133055","journal-title":"Int J Cancer"},{"issue":"23","key":"8818_CR34","doi-asserted-by":"publisher","first-page":"23668","DOI":"10.18632\/aging.103820","volume":"12","author":"K Xu","year":"2020","unstructured":"Xu K, Chen B, Li B et al (2020) DNMT3B silencing suppresses migration and invasion by epigenetically promoting miR-34a in bladder cancer. Aging 12(23):23668","journal-title":"Aging"},{"key":"8818_CR35","doi-asserted-by":"crossref","unstructured":"Ying Y, Li J, Xie H et al (2020) CCND1, NOP14 and DNMT3B are involved in miR-502\u20105p\u2013mediated inhibition of cell migration and proliferation in bladder cancer. Cell Prolif, 53(2), e12751","DOI":"10.1111\/cpr.12751"},{"issue":"1","key":"8818_CR36","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/jcp.26591","volume":"234","author":"RB Zo","year":"2019","unstructured":"Zo RB, Long Z (2019) MiR-124\u20103p suppresses bladder cancer by targeting DNA methyltransferase 3B. J Cell Physiol 234(1):464\u2013474","journal-title":"J Cell Physiol"},{"issue":"9","key":"8818_CR37","first-page":"1295","volume":"40","author":"Y Cao","year":"2020","unstructured":"Cao Y, Xu K, Chen B et al (2020) Expression of DNMT3b in human bladder cancer tissue and its correlation with clinical prognosis. Nan Fang yi ke da xue xue bao = Journal of Southern Medical University 40(9):1295\u20131300","journal-title":"Nan Fang yi ke da xue xue bao = Journal of Southern Medical University"},{"issue":"7","key":"8818_CR38","first-page":"4606","volume":"14","author":"R Li","year":"2022","unstructured":"Li R, Chen X, Li X et al (2022) A four-miRNA signature in serum as a biomarker for bladder cancer diagnosis. Am J Translational Res 14(7):4606","journal-title":"Am J Translational Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08818-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-08818-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08818-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T16:11:59Z","timestamp":1700928719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-08818-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["8818"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-08818-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,30]]},"assertion":[{"value":"21 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Institute Review Board of the Faculty of Medicine, Zagazig University (ZU-IRB#9014\/25-10-2021).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}